{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T20:09:03Z","timestamp":1778098143707,"version":"3.51.4"},"reference-count":12,"publisher":"BMJ","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ Case Reports"],"abstract":"<jats:title\/><jats:p>In this rare case, the patient presented with opsoclonus, myoclonus and ataxia. Serological and imaging studies revealed high glutamic acid decarboxylase antibody (GAD-Ab) levels. High-dose corticosteroids were of no benefit and subsequent intravenous immunoglobulin (IVIg) administration proved resolution of the condition. Levetiracetam proved useful in symptomatically controlling the myoclonus. Follow-up GAD-Ab levels were within normal limits.<\/jats:p>","DOI":"10.1136\/bcr-2012-006339","type":"journal-article","created":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T13:08:04Z","timestamp":1344517684000},"page":"bcr2012006339","source":"Crossref","is-referenced-by-count":10,"title":["Presentation of opsoclonus myoclonus ataxia syndrome with glutamic acid decarboxylase antibodies"],"prefix":"10.1136","volume":"2012","author":[{"given":"Hanul Srinivas","family":"Bhandari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2012,8,9]]},"reference":[{"key":"2025042702500528000_2012.aug07_1.bcr2012006339.1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.25.3.271"},{"key":"2025042702500528000_2012.aug07_1.bcr2012006339.2","doi-asserted-by":"publisher","DOI":"10.4103\/0972-2327.70876"},{"key":"2025042702500528000_2012.aug07_1.bcr2012006339.3","doi-asserted-by":"crossref","unstructured":"Mehta SH Morgan JC Sethi KD . Paraneoplastic movement disorders. Curr Neurol Neurosci Rep 2009;286\u201391.","DOI":"10.1007\/s11910-009-0043-4"},{"key":"2025042702500528000_2012.aug07_1.bcr2012006339.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2008.03.005"},{"key":"2025042702500528000_2012.aug07_1.bcr2012006339.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2010.03.024"},{"key":"2025042702500528000_2012.aug07_1.bcr2012006339.6","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.166"},{"key":"2025042702500528000_2012.aug07_1.bcr2012006339.7","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e3181d9bb3b"},{"key":"2025042702500528000_2012.aug07_1.bcr2012006339.8","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0b013e3280126b51"},{"key":"2025042702500528000_2012.aug07_1.bcr2012006339.9","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21123"},{"key":"2025042702500528000_2012.aug07_1.bcr2012006339.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2009.03.010"},{"key":"2025042702500528000_2012.aug07_1.bcr2012006339.11","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199206000-00002"},{"key":"2025042702500528000_2012.aug07_1.bcr2012006339.12","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-52014-2.00031-8"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2012-006339","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T09:50:16Z","timestamp":1745747416000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2012-006339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,9]]},"references-count":12,"alternative-id":["10.1136\/bcr-2012-006339"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2012-006339","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,9]]}}}